Complement-dependent cytotoxicity (CDC) is an integral part of our immune defense system by activating the complement system to eliminate target cells. However, CDC dysregulation can contribute to autoimmune diseases and inflammatory pathologies.
In this blog post, we will explore the significance of CDC activity assessment in the development of therapeutics that modulate the complement system. By inhibiting or activating complement, these therapeutics can prevent unwanted complement activation in specific disease settings.